CICC
GSK icon

Capital Investment Counsel (Colorado)’s GSK GSK Stock Holding History

Capital Investment Counsel (Colorado)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43,054
Closed -$1.85M – 136
2024
Q1 		$1.85M Sell
43,054
-9,466
-18% -$390K 0.4% 71
2023
Q4 		$1.95M Buy
+52,520
New +$1.89M 0.73% 62

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Capital Investment Counsel (Colorado)'s GSK Position: Q2 2024 in Review

Capital Investment Counsel (Colorado) sold out of GSK (GSK) in Q2 2024, closing a stake of 43,054 shares — an estimated $1.85M sold.

Capital Investment Counsel (Colorado) first reported a position in GSK in Q4 2023 and held it in 2 quarters. The position peaked at $1.95M in Q4 2023. 885 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Capital Investment Counsel (Colorado) reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Capital Investment Counsel (Colorado) sold 43,054 GSK shares in Q2 2024, an estimated $1.85M.
  • Capital Investment Counsel (Colorado) first reported a position in GSK in Q4 2023 and held it in 2 quarters.
  • Capital Investment Counsel (Colorado)'s GSK position peaked at $1.95M in Q4 2023.
  • 885 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q2 2024, filed 14 Aug 2024.